Amazon tempts pharma R&D outfits with low-cost data storage

Amazon has revealed a new cloud-based service called Glacier for archiving large amounts data on the cheap. The web giant ($AMZN) underlined the relatively low monthly storage rate of 1 cent per gigabyte, and the company highlighted a number of typical use cases that including housing data from drug research. Biotech and pharma companies--whose data are the lifeblood of their vital R&D activities--often store massive amounts of data referenced during drug development to check experimental results, according to Amazon. Life sciences outfits typically store such data on tape-based systems and stash copies in multiple secure locations. Amazon's pitch to biopharma groups is to let Amazon Web Services, the company's cloud computing unit, handle the management of those data and relieve drugmakers of the operational overhead. So far, one of the takers in life sciences is DNA sequencing group Complete Genomics ($GNOM). Article

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.